DeutschNewstral
Article
pressherald.com on 2017-11-07 10:00
Portland biotech firm ImmuCell completes $20 million expansion
Related news
- ImmuCell of Portland sells technology to British firmpressherald.com
- OPortland-based biotech firm completes move to Bay Areaoregonbusiness.com
- ImmuCell completes $5.9 million public offeringpressherald.com
- Portland councilors favor tax break discussion, but not on current ImmuCell projectpressherald.com
Portland biotech firm sold to global drug developerbizjournals.com- Portland tech firm Tilson to receive up to $100 million investmentpressherald.com
- ImmuCell suffers $2.3 million loss in 2018pressherald.com
Portland cybersecurity firm lands $50 millionoregonlive.com- Portland area biotech raises $65M from investors for expansionbizjournals.com
- Portland co-working firm continues its expansion outside of Oregonbizjournals.com
- Portland loses growing biotech firm to Vancouver waterfront spacebizjournals.com
- Montgomery County biotech firm completes reverse merger, raises $77.8 millionbizjournals.com
- Ronald McDonald House in Portland pursues $2.3 million expansionpressherald.com
Maine air service plans $4.35 million expansion at Portland jetportbangordailynews.com- Maine Med reaches $150 million goal for Portland hospital expansionpressherald.com
- Portland panel endorses sale of city-owned plot to local biotech firmpressherald.com
- Portland’s ImmuCell reports second-quarter sales boostpressherald.com
- Pacific West Bank raises $27.2 million, eyes Portland expansionbizjournals.com
- Portland sports tech firm KinoTek scores $2.1 million investmentpressherald.com
- Chicago firm buys South Portland medical complex for $30 millionpressherald.com